Table 2.
Model | B (SE) for Female Sex† | p-value |
---|---|---|
Unadjusted | 0.105 (0.003) | <0.001 |
+ Age, race | 0.096 (0.003) | <0.001 |
+ Age, race, medical history‡ | 0.084 (0.003) | <0.001 |
+ Age, race, medical history, clinical presentation§ | 0.092 (0.003) | <0.001 |
+ Age, race, medical history, clinical presentation, treatment|| | 0.078 (0.002) | <0.001 |
The intercept for male sex in the unadjusted model was 0.418 (SE 0.002), indicating that men lost on average 41.8% of their remaining life after AMI.
Parameter estimates reflect average difference in life expectancy for women compared with men. For example, prior to adjustment, women lost on average 10.5% more (or 52.3% total) of their remaining life after AMI than men.
Medical history covariates include history of chronic heart failure, diabetes mellitus hypertension, coronary artery disease, and smoking.
Clinical presentation covariates include anterior AMI, ST-segment elevation AMI, cardiac arrest, Killip class, and renal insufficiency.
Treatment covariates include revascularization within 30 days, fibrinolytic therapy, aspirin and beta-blockers at arrival.